If you require outsourcing of the in-life portion of your compound assessment, Iconix will design the study in collaboration with you, and manage the study with a selected and highly qualified group of CROs. Because this is integral to a successful analysis, Iconix charges only a small management fee for this service, and passes the costs directly to the Client. Having Iconix manage the outsourcing of the in-life study relieves you of that time-consuming burden, and ensures that the study is carried out in a way that allows direct comparison with the DrugMatrix reference dataset. Contact Iconix Customer Service for further information and estimates of costs for this portion of a study.